|
The
request for new information is part of the U.S. anti-trust
body's review process, which is usually done to check if a deal
has any anti-competitive consequences.
Both parties plan to promptly respond to the request, One
Medical said.
Analysts have said Amazon's limited healthcare presence should
minimize antitrust issues, but there were still risks, given the
company faces scrutiny over its dominant tech position in the
market.
After the deal was announced, U.S. Senator Amy Klobuchar, who is
also the chairwoman of a subcommittee overseeing antitrust
issues, urged the FTC to investigate the proposed deal due to
Amazon's "history of engaging in business practices that raise
serious anticompetitive concerns".Amazon in July had agreed to
buy One Medical as it sought to expand its virtual healthcare
offering and add brick-and-mortar doctors' offices.
The company last month said it planned to shut down its virtual
healthcare service by the end of this year, as a deal to buy One
Medical awaited regulatory approval.
(Reporting by Leroy Leo, Praveen Paramasivam and Kannaki Deka in
Bengaluru;Editing by Vinay Dwivedi)
[© 2022 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|
